Literature DB >> 33420582

Chinese Expert Consensus on Clinical Application of Oral Ginkgo biloba Preparations (2020).

Ke-Ji Chen.   

Abstract

Entities:  

Year:  2021        PMID： 33420582     DOI： 10.1007/s11655-021-3289-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  22 in total

1.  Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.

Authors:  V Lamant; G Mauco; P Braquet; H Chap; L Douste-Blazy
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858

2.  EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1.

Authors:  Jin-Yi Tsai; Kuo-Hui Su; Song-Kun Shyue; Yu Ru Kou; Yuan-Bin Yu; Sheng-Huang Hsiao; An-Na Chiang; Yuh-Lin Wu; Li-Chieh Ching; Tzong-Shyuan Lee
Journal:  Cardiovasc Res       Date:  2010-07-08       Impact factor: 10.787

3.  Ginkgo biloba extract reducing myocardium cells apoptosis by regulating apoptotic related proteins expression in myocardium tissues.

Authors:  Zeng Yong Qiao; Jian Hua Huang; Jiang Wei Ma; Ya Wei Xu; Jun Xie; Hua Jin Liu; San Jun Xiong; Guang Hao Ge
Journal:  Mol Biol Rep       Date:  2013-12-08       Impact factor: 2.316

Review 4.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

5.  Cardio-protection by Ginkgo biloba extract 50 in rats with acute myocardial infarction is related to Na⁺-Ca²⁺ exchanger.

Authors:  Ai-Hua Liu; Yi-Min Bao; Xing-Yu Wang; Zhi-Xiong Zhang
Journal:  Am J Chin Med       Date:  2013       Impact factor: 4.667

6.  Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: I. cardiomyocytes.

Authors:  Rick Schneider; Klaus Welt; Wolfram Aust; Heinz Löster; Günther Fitzl
Journal:  Histol Histopathol       Date:  2008-07       Impact factor: 2.303

Review 7.  Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.

Authors:  Teris A van Beek; Paola Montoro
Journal:  J Chromatogr A       Date:  2009-01-15       Impact factor: 4.759

8.  EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes.

Authors:  Soo Lim; Ji Won Yoon; Seon Mee Kang; Sung Hee Choi; Bong Jun Cho; Min Kim; Ho Seon Park; Hyun Ju Cho; Hayley Shin; Young-Bum Kim; Hyo Soo Kim; Hak Chul Jang; Kyong Soo Park
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

9.  Effect of Ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia reperfusion rats.

Authors:  Shaoping Lu; Xia Guo; Pinting Zhao
Journal:  Molecules       Date:  2011-11-02       Impact factor: 4.411

Review 10.  Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®.

Authors:  Nagaendran Kandiah; Paulus Anam Ong; Turana Yuda; Li-Ling Ng; Kaysar Mamun; Reshma Aziz Merchant; Christopher Chen; Jacqueline Dominguez; Simeon Marasigan; Encarnita Ampil; Van Thong Nguyen; Suraya Yusoff; Yee Fai Chan; Fee Mann Yong; Orapitchaya Krairit; Chuthamanee Suthisisang; Vorapun Senanarong; Yong Ji; Ramesh Thukral; Ralf Ihl
Journal:  CNS Neurosci Ther       Date:  2019-02       Impact factor: 5.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.